Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection (original) (raw)
Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate
maftuchah rochmanti
Journal of Forensic Medicine, 2021
View PDFchevron_right
Optimizing Treatment Outcomes in Severe Community-Acquired Pneumonia
Felipe Rodríguez Castro
American Journal of Respiratory Medicine, 2003
View PDFchevron_right
Improvement of antibiotic therapy and ICU survival in severe non-pneumococcal community-acquired pneumonia: a matched case–control study
Rafael Sierra
Critical Care, 2015
View PDFchevron_right
Etiology, Reasons for Hospitalization, Risk Classes, and Outcomes of Community‐Acquired Pneumonia in Patients Hospitalized on the Basis of Conventional Admission Criteria
Francesc Gudiol
Clinical Infectious Diseases, 2001
View PDFchevron_right
Time for first antibiotic dose is not predictive for the early clinical failure of moderate–severe community-acquired pneumonia
C. A. J. M. Gaillard, Andy Hoepelman
European Journal of Clinical Microbiology & Infectious Diseases, 2009
View PDFchevron_right
Antibiotic treatment outcomes in community-acquired pneumonia
Yavuz Havlucu
TURKISH JOURNAL OF MEDICAL SCIENCES
View PDFchevron_right
Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis
Ahsan Akram
Clinical Microbiology and Infection, 2011
View PDFchevron_right
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes
Francesco Blasi
International Journal of Infectious Diseases, 2013
View PDFchevron_right
Rapid Antibiotic Delivery and Appropriate Antibiotic Selection Reduce Length of Hospital Stay of Patients With Community-Acquired Pneumonia
David Battleman
Archives of internal medicine, 2002
View PDFchevron_right
Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia
Jacqueline Pugh
The American Journal of Medicine, 2004
View PDFchevron_right
Severe Community‐Acquired Pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission
Miquel Ferrer
Clinical Infectious Diseases, 2009
View PDFchevron_right
Bacterial community-acquired pneumonia: risk factors for mortality and supportive therapies
H. Lode
Intensive Care Medicine, 2009
View PDFchevron_right
Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit
Jessica Ruiz
2010
View PDFchevron_right
Antibiotic Prescription for Community-Acquired Pneumonia in the Intensive Care Unit: Impact of Adherence to Infectious Diseases Society of America Guidelines on Survival
Jordi Rello
Clinical Infectious Diseases, 2005
View PDFchevron_right
Severe community-acquired pneumonia: Severity and management
Catia Cilloniz
Community Acquired Infection, 2015
View PDFchevron_right
Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough
Ignacio Martín-loeches
Intensive Care Medicine, 2009
View PDFchevron_right
Hospitalization decision in patients with community-acquired pneumonia: A prospective cohort study
Darrell Smith
American Journal of Medicine, 1990
View PDFchevron_right
Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation
K. Seifert
Respiratory Medicine, 2000
View PDFchevron_right
Impact of The Joint Commission Pneumonia Core Measure on Antibiotic Use and Selection for Community-Acquired Pneumonia in the Emergency Room
Marilyn Bulloch
Hospital Pharmacy, 2016
View PDFchevron_right
Impact of Guideline-Concordant Empiric Antibiotic Therapy in Community-Acquired Pneumonia
David Burgess
The American Journal of Medicine, 2006
View PDFchevron_right
Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial
Andy Hoepelman
BMJ, 2006
View PDFchevron_right
Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria
Gilles Clermont
American journal of respiratory and critical care medicine, 2002
View PDFchevron_right
The Impact of First Timing of Antibiotics for Community Acquired Pneumonia in Emergency Department
Casey Clements
2020
View PDFchevron_right
Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors
Jeroen Schouten
Journal of Antimicrobial Chemotherapy, 2005
View PDFchevron_right
Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia
Neera Agrwal
Respiratory Medicine, 2012
View PDFchevron_right
Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
Amaia Bilbao
View PDFchevron_right
A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit
Benoit Guery
Intensive Care Medicine, 1995
View PDFchevron_right
Outcomes of Patients Hospitalized With Community-Acquired, Health Care-Associated, and Hospital-Acquired Pneumonia
Marco Falcone
View PDFchevron_right